Cas12a (cpf1) Guide Design: Which Tools Support It

Cas12a guide RNA design tools are a narrower question than general CRISPR software, because most of the tool landscape was built SpCas9-first and Cas12a (also called Cpf1) support varies from native to absent. The good news for researchers: the two free standards both carry it with documentation. CHOPCHOP v3 added a dedicated Cas12a mode with a deep-learning efficiency score for the nuclease, inside its gene-first workflow. CRISPOR supports Cpf1 with the Seq-DeepCpf1 on-target score and handles its cohesive rather than blunt cut ends. Route between them the way the general CHOPCHOP vs CRISPOR comparison recommends — exploration to the gene-first tool, scoring depth to the sequence-first tool — and note the licensing boundary if your Cas12a project has commercial ties.

Quick Answer: Two Tools Carry Cas12a Natively

Start with CHOPCHOP when you are exploring from a gene and want the mode context around Cas12a — its workflow supports multiple effectors, so a project that may pivot between nucleases designs in one place, and the Cas12a mode carries its own efficiency score rather than borrowed Cas9 logic.

Start with CRISPOR when you have the sequence and are committing to guides: its Cpf1 support includes the Seq-DeepCpf1 nuclease-specific score and the same mismatch-depth off-target analysis it applies to any supported nuclease, plus the cloning and validation handoff (oligos, primers, CRISPResso-ready outputs) that saves the afternoon after design.

One boundary decides some projects by itself: CHOPCHOP's web service is restricted to non-profit and academic use, while CRISPOR's open-source code can be self-hosted — a decisive difference for companies running Cas12a work.

What Cas12a Support Actually Includes

Nuclease support is more than recognizing a PAM, and the two publications show what real support looks like. CHOPCHOP v3 lists Cas12a among its effectors with a dedicated efficiency score — a deep-learning model developed for the nuclease — and applies its genome-wide off-target prediction in Cas12a mode. The tool's broader mode set (knock-in homology arms, CRISPRi/a, paired nickases) surrounds the Cas12a path with options a pivoting project uses.

CRISPOR's Cpf1 support shows the same seriousness from the sequence-first direction: Seq-DeepCpf1 as the on-target efficiency score, off-target analysis to four mismatches in the selected genome with CFD scoring, and — a detail that matters for downstream cloning — the tool's representation of Cpf1's cohesive rather than blunt cut ends, which affects how junctions and verification amplicons should be planned.

What generic support misses is exactly this layer: a tool that merely scans for PAM-adjacent sites without nuclease-specific scoring gives you candidates, not rankings — and directories rarely tell you which layer a given tool implements. The two publications linked above are the answer to that ambiguity: the support is documented, scored, and citable.

Cas12a Support: Side-by-Side

Routing a Cas12a Project Between Them

• Exploring nucleases on one gene: CHOPCHOP — compare Cas12a candidates against other effectors in one session before committing.
• Committing to guides from a known sequence: CRISPOR — Seq-DeepCpf1 scoring, mismatch-depth off-targets, and the oligo/primer handoff in one run.
• Important guides: cross-check — run the finalists through both tools; agreement between two independent scoring stacks is cheap reassurance.
• Commercial or CRO-adjacent work: the licensing row decides — self-hosted CRISPOR, or a platform whose terms your organization has cleared.

The routing mirrors the general pair logic because Cas12a does not change the tools' shapes — it changes which of their capabilities you are relying on. The free-versus-commercial comparison extends the licensing decision, and because Cas12a is a common choice in plant editing, the plant CRISPR software guide covers the genome-availability questions that accompany it there.

Where Platform CRISPR Tools Fit

Platforms with embedded CRISPR design — Benchling's CRISPR tools, ZettaCRISPR in the Zettalab workspace — advertise guide design with on- and off-target scoring without enumerating supported nucleases on their product pages. For Cas12a work, that gap has one honest answer: ask in the demo. "Show me a Cas12a design with its nuclease-specific score" either produces a working screen or a roadmap answer, and either response tells you what you need to know before routing nuclease-specific science to the platform. When a platform does support it, what it adds over the free tools is the usual platform value — guides as registered entities beside records — not better guide science.

A Same-Target Cas12a Test

1. Pick one real Cas12a target in your organism of record.
2. Run it gene-first in CHOPCHOP's Cas12a mode and sequence-first in CRISPOR.
3. Compare candidate sets and, where they disagree, find which nuclease-specific score explains the difference.
4. Take one finalist to the handoff you actually use — oligo order or validation amplicon — and count steps in each tool.
5. If your work is commercial-adjacent, stop at the licensing row before getting attached to either workflow.

One afternoon, no cost for academic users, and the answer is specific to the genome and project that actually matter to you.

Frequently Asked Questions

Which free tools support Cas12a guide design?

CHOPCHOP and CRISPOR, both with documented support: CHOPCHOP v3 includes a dedicated Cas12a mode with a deep-learning efficiency score, and CRISPOR supports Cpf1 with the Seq-DeepCpf1 on-target score. Both are free for academic users on different licensing terms.

Does CRISPOR score Cas12a guides?

Yes. CRISPOR's publication documents Seq-DeepCpf1 as the nuclease-specific on-target score for Cpf1, alongside the mismatch-depth off-target analysis it applies to supported nucleases — so Cas12a guides get the same scoring rigor as Cas9 guides, with nuclease-appropriate models.

Does CHOPCHOP support Cas12a?

Yes. CHOPCHOP v3 lists Cas12a/Cpf1 among its supported effectors with a deep-learning efficiency score for the nuclease, inside its gene-first workflow with genome-wide off-target prediction — academic and non-profit use under its stated terms.

How does Cas12a guide design differ from Cas9?

The nucleases differ in PAM and cut structure, which is exactly why nuclease-specific modes and scores exist: a serious tool encodes Cas12a's requirements in a dedicated mode rather than reusing Cas9 logic. For tool selection, the practical rule is simpler — use only tools whose Cas12a support is documented, and score candidates with nuclease-specific models.